Short answer
Privia Health Group, Inc. (PRVA) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026.
Privia Health Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Press release attached as Exhibit 99.1 with financial results and management commentary
Item EX-99.1 · Exhibit EX-99.1
- 2Q’26 revenue $632.6M, up 21.4%, with net income $9.0M, up 236.7% year over year
- Adjusted EBITDA $37.4M, up 29.1%; margin expanded to 28.3% from 25.2%
- Attributed lives increased 19.2% to 1.647M, supporting value-based care growth
- Full-year guidance raised for attributed lives to 1.625M–1.650M and revenue to $2.45B high end
- Adjusted EBITDA guidance raised to $145M–$155M, with 70%–80% expected free-cash-flow conversion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Privia Health Group, Inc. 8-K filings
Get the next PRVA 8-K as it lands
Follow PRVA for push alerts, or ask the research agent what this filing means.